Effect of noradrenaline (NA) alone (A) and NA with α1A- (B), α1B- (C), α1D- (D) and α1A,B,D (E)–adrenoreceptors (ARs) antagonists (a dose of 10⁻⁴ M) on the tension of co... by Barbara Jana (9110179)

Effect of noradrenaline (NA) alone (A) and NA with α1A- (B), α1B- (C), α1D- (D) and α1A,B,D (E)–adrenoreceptors (ARs) antagonists (a dose of 10⁻⁴ M) on the amplitude of... by Barbara Jana (9110179)

Effect of noradrenaline (NA) alone (A) and NA with α1A- (B), α1B- (C), α1D- (D) and α1A,B,D (E)–adrenoreceptors (ARs) antagonists (a dose of 10⁻⁴ M) on the amplitude of... by Barbara Jana (9110179)

Effect of noradrenaline (NA) alone (A) and NA with α1A- (B), α1B- (C), α1D- (D) and α1A,B,D (E)–adrenoreceptors (ARs) antagonists (a dose of 10⁻⁴ M) on the frequency of... by Barbara Jana (9110179)

Decreased self-renewal capacity associated with senescence was prevented in human MSCs following treatment with Ki16425, an LPA₁/LPA₃ antagonist. by Masahiko Kanehira (183764)

“…Fold-change represents decrease in band intensity of Ki16425 treatment for 18 days compared with a control treatment for the same period of time. …”

S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis by Xiaolin Liu (403100)

“…We find that gene expression of s100a9 was higher in NAFL group compared with control, and was increased in NASH groups and decreased in NAFL + T2DM group compared with NAFL. …”

<i>In vivo</i> silencing (RNAi) of pairing-dependent lincRNAs decreases the number of <i>S</i>. <i>mansoni</i> adult worms recovered from infected mice. by Gilbert O. Silveira (7376819)

Summary of POU UVC LED influent and effluent microbial water quality and log-removals. E. coli was not detected in any influent or effluent samples. Total coliform concentrations s... by Hania Zanib (21864477)

Microarray analysis of genes modulated by siRNA treatments. by Giorgia Urbinati (554921)

Glycolytic inhibition by decreasing availability of NAD⁺ contributes to defective hyphae and biofilm formation of <i>nuo2</i>Δ/Δ cells under mannitol condition. by Xinhua Huang (1905940)

D452A, E464A, E470A, and E475A mutations decreased the calcium sensitivity. by Qinghuan Xiao (573411)

Susceptibility to COPD: Differential Proteomic Profiling after Acute Smoking by Lorenza Franciosi (600602)

“…SerpinB3 and Uteroglobin decreased after acute smoke exposure in young non-susceptible individuals exclusively, whereas Peroxiredoxin I, S100A9, S100A8, ALDH3A1 (Aldehyde dehydrogenase 3A1) decreased both in young susceptible and non-susceptible individuals, changes being significantly different between groups for Uteroglobin with iTRAQ and for Serpin B3 with iTRAQ and ELISA measures. …”

Identification of OPG147 as a conserved inhibitor of the cGAS-mediated pathway. by Xue-Mei Yi (18851202)

Decrease in proliferation after ENU-exposure as decrease in BrdU immunostaining. by Vivian Capilla-Gonzalez (336046)

“…<p>Micrograph of the BrdU+ cells immunolabeled with DAB showed a decrease in the proliferation in the SVZ (B) and DG (D) of treated animals, compared with control group (A and C, respectively). …”

TGFβ1 expression was increased, and RASAL1 expression was decreased in NTM cells in response to a hypoxic environment. by Fiona McDonnell (2636635)

“…A 0hr Control was set to 100%, and the normoxic and hypoxic results were presented as a percentage of this; Normoxic = 95.5%, Hypoxic = 159.4% (P<0.01). n = 3 *P<0.05, **P<0.01. …”

Overall survival (OS) of patient with newly diagnosed AML in South Korea, from 2011 to2020 by subpopulation: (a) Overall population, (b) OS by Age group, (c) OS by Treatment, (d) O... by Hyun Jin Han (18592254)

Enhancement of <i>atl</i>^<i>2</i> poly-UB aggregate phenotype by TrpA1 activation. by Saurabh Srivastav (9585817)

The first regression of log of confirmed cases vs consecutive days for 4 of the total of 50 countries is shown. by Adam Kaplin (10156481)

Global number of meningitis deaths by etiology and age group in 1990(A) and 2021(B). by Jun Li (6494)

Baseline characteristics of patients. by Seydou Goro (17847203)

“…Using the number of competitors per distance method, our study showed that a “highly competitive” and “moderately competitive” markets decreased mortality by 31% [OR: 0.69 (0.59, 0.80); p<0.001] and by 12% respectively [OR: 0.88 (0.79, 0.99); p<0.03], compared to the “non-competitive” market. …”